Related Articles
Effect of bortezomib in combination with cisplatin and 5‑fluorouracil on 4T1 breast cancer cells
Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade
A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib
Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3
Proteasome inhibitors decrease paclitaxel‑induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1